Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Transcriptome sequencing of malignant pleural mesothelioma tumors.

Sugarbaker DJ, Richards WG, Gordon GJ, Dong L, De Rienzo A, Maulik G, Glickman JN, Chirieac LR, Hartman ML, Taillon BE, Du L, Bouffard P, Kingsmore SF, Miller NA, Farmer AD, Jensen RV, Gullans SR, Bueno R.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3521-6. doi: 10.1073/pnas.0712399105. Epub 2008 Feb 26.

PMID:
18303113
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.

Dong L, Jensen RV, De Rienzo A, Gordon GJ, Xu Y, Sugarbaker DJ, Bueno R.

BMC Med Genet. 2009 Dec 31;10:149. doi: 10.1186/1471-2350-10-149.

PMID:
20043850
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.

Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Yeap BY, Sugarbaker DJ, Bueno R.

J Pathol. 2007 Mar;211(4):439-46.

PMID:
17253597
[PubMed - indexed for MEDLINE]
4.

Second generation sequencing of the mesothelioma tumor genome.

Bueno R, De Rienzo A, Dong L, Gordon GJ, Hercus CF, Richards WG, Jensen RV, Anwar A, Maulik G, Chirieac LR, Ho KF, Taillon BE, Turcotte CL, Hercus RG, Gullans SR, Sugarbaker DJ.

PLoS One. 2010 May 13;5(5):e10612. doi: 10.1371/journal.pone.0010612.

PMID:
20485525
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.

Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Edenfield HR, Glickman JN, Yeap BY, Sugarbaker DJ, Bueno R.

J Pathol. 2007 Mar;211(4):447-54.

PMID:
17253596
[PubMed - indexed for MEDLINE]
6.

Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.

Goto Y, Shinjo K, Kondo Y, Shen L, Toyota M, Suzuki H, Gao W, An B, Fujii M, Murakami H, Osada H, Taniguchi T, Usami N, Kondo M, Hasegawa Y, Shimokata K, Matsuo K, Hida T, Fujimoto N, Kishimoto T, Issa JP, Sekido Y.

Cancer Res. 2009 Dec 1;69(23):9073-82. doi: 10.1158/0008-5472.CAN-09-1595. Epub 2009 Nov 3.

PMID:
19887624
[PubMed - indexed for MEDLINE]
Free Article
7.

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.

Suraokar MB, Nunez MI, Diao L, Chow CW, Kim D, Behrens C, Lin H, Lee S, Raso G, Moran C, Rice D, Mehran R, Lee JJ, Pass HI, Wang J, Momin AA, James BP, Corvalan A, Coombes K, Tsao A, Wistuba II.

Ann Oncol. 2014 Jun;25(6):1184-92. doi: 10.1093/annonc/mdu127. Epub 2014 Mar 24.

PMID:
24669013
[PubMed - indexed for MEDLINE]
8.

Absence of post-transcriptional RNA modifications of BCL10 in human malignant mesothelioma and colorectal cancer.

Apostolou S, Murthy SS, Kolachana P, Jhanwar SC, Testa JR.

Genes Chromosomes Cancer. 2001 Jan;30(1):96-8.

PMID:
11107182
[PubMed - indexed for MEDLINE]
9.

Gene expression profiling identifies matriptase overexpression in malignant mesothelioma.

Hoang CD, D'Cunha J, Kratzke MG, Casmey CE, Frizelle SP, Maddaus MA, Kratzke RA.

Chest. 2004 May;125(5):1843-52.

PMID:
15136399
[PubMed - indexed for MEDLINE]
10.

Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.

Usami N, Fukui T, Kondo M, Taniguchi T, Yokoyama T, Mori S, Yokoi K, Horio Y, Shimokata K, Sekido Y, Hida T.

Cancer Sci. 2006 May;97(5):387-94.

PMID:
16630136
[PubMed - indexed for MEDLINE]
11.

Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.

Modi S, Kubo A, Oie H, Coxon AB, Rehmatulla A, Kaye FJ.

Oncogene. 2000 Sep 21;19(40):4632-9.

PMID:
11030152
[PubMed - indexed for MEDLINE]
Free Article
12.

Polycomb repressor complex-2 is a novel target for mesothelioma therapy.

Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P, Filie A, Zhang M, Hong JA, Walker RL, Zhu YJ, Ripley RT, Mathur A, Liu F, Yang M, Meltzer PA, Marquez VE, De Rienzo A, Bueno R, Schrump DS.

Clin Cancer Res. 2012 Jan 1;18(1):77-90. doi: 10.1158/1078-0432.CCR-11-0962. Epub 2011 Oct 25.

PMID:
22028491
[PubMed - indexed for MEDLINE]
Free Article
13.

The alpha folate receptor is highly activated in malignant pleural mesothelioma.

Bueno R, Appasani K, Mercer H, Lester S, Sugarbaker D.

J Thorac Cardiovasc Surg. 2001 Feb;121(2):225-33.

PMID:
11174727
[PubMed - indexed for MEDLINE]
14.

A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.

Melaiu O, Cristaudo A, Melissari E, Di Russo M, Bonotti A, Bruno R, Foddis R, Gemignani F, Pellegrini S, Landi S.

Mutat Res. 2012 Apr-Jun;750(2):132-40. doi: 10.1016/j.mrrev.2011.12.003. Epub 2011 Dec 15. Review.

PMID:
22198210
[PubMed - indexed for MEDLINE]
15.

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.

Tallet A, Nault JC, Renier A, Hysi I, Galateau-Sallé F, Cazes A, Copin MC, Hofman P, Andujar P, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D.

Oncogene. 2014 Jul 10;33(28):3748-52. doi: 10.1038/onc.2013.351. Epub 2013 Aug 26.

PMID:
23975423
[PubMed - indexed for MEDLINE]
16.

Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.

De Rienzo A, Richards WG, Yeap BY, Coleman MH, Sugarbaker PE, Chirieac LR, Wang YE, Quackenbush J, Jensen RV, Bueno R.

Clin Cancer Res. 2013 May 1;19(9):2493-502. doi: 10.1158/1078-0432.CCR-12-2117. Epub 2013 Mar 14.

PMID:
23493352
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells.

Washimi K, Yokose T, Yamashita M, Kageyama T, Suzuki K, Yoshihara M, Miyagi Y, Hayashi H, Tsuji S.

PLoS One. 2012;7(7):e39889. doi: 10.1371/journal.pone.0039889. Epub 2012 Jul 2.

PMID:
22768319
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.

Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L, Creaney J, Lake RA, Zakowski MF, Reva B, Sander C, Delsite R, Powell S, Zhou Q, Shen R, Olshen A, Rusch V, Ladanyi M.

Nat Genet. 2011 Jun 5;43(7):668-72. doi: 10.1038/ng.855.

PMID:
21642991
[PubMed - indexed for MEDLINE]
19.

Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.

Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Ramaswamy S, Richards WG, Sugarbaker DJ, Bueno R.

Cancer Res. 2002 Sep 1;62(17):4963-7.

PMID:
12208747
[PubMed - indexed for MEDLINE]
Free Article
20.

MicroRNAs dysregulation in human malignant pleural mesothelioma.

Balatti V, Maniero S, Ferracin M, Veronese A, Negrini M, Ferrocci G, Martini F, Tognon MG.

J Thorac Oncol. 2011 May;6(5):844-51. doi: 10.1097/JTO.0b013e31820db125.

PMID:
21358347
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk